Although we have talked a lot about them, AI and machine learning are the new shiny toys of healthcare — this comes with pros and cons. With how versatile these technologies are, we are constantly finding new and exciting ways and areas to apply them in healthcare. However, since the technology can be applied in
Explore this post and more from the Damnthatsinteresting community
How to create impactful science that drives meaningful change with Dr. Cornella.
The Boxed Warning is based on the FDA’s review of a postmarketing case of serious liver injury with fezolinetant reported to the FAERS database.
Explore this post and more from the Damnthatsinteresting community
Today, the FDA approved the first medication for the treatment of moderate to severe obstructive sleep apnea in adults with obesity.
Costs for planning and executing provider-led joint ventures are poised to increase without the Federal Trade Commission’s 2000 collaboration guidelines.
The startup has run into problem after problem on its new artificial-intelligence project, code-named Orion.
Evan David Seigerman, BMO managing director, joins ‘Fast Money’ to discuss Novo sinking on its obesity drug data.
New data support the growing consensus on the effectiveness and safety of sirolimus in managing complex vascular anomalies.
A quiet suburban mom, a hard-drinking war correspondent and an Arctic researcher were hiding in plain sight, championed by the Kremlin’s No. 1 fan of…
